Algo version: 0.98b
Solara Active Pharma is listed at the NSE Exchange
Solara Active Pharma [SOLARA.NS]
NSE Sector: Healthcare Industry:Drug Manufacturers—Specialty & Generic

Is Solara Active Pharma stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Solara Active Pharma pays dividends. Last time was Friday 24th of September 2021 where the investors holding the stock on Wednesday 18th of August 2021 were paid INR3 per share. Over the last 4 times between 2019 and 2021, Solara Active Pharma has paid INR14 with an average of INR3.5 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Solara Active Pharma 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was INR405.57, you would have made a profit of INR341.28 per share or 84.15%

Yes, the average daily trading liquidity for Solara Active Pharma is INR194 609 thousand. You should therefore be able to get in and out of your positions relatively fast.

Solara Active Pharma has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.15, the company's ability to pay off the debt is normal. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Solara Active Pharma to be high [0.7 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.